Cargando…

SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo

Ocular angiogenesis is a major cause of severe vision loss, which can affect several parts of the eye, including the retina, choroid and cornea. Vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors have demonstrated great potential for treating ocular angiogenesis and SKLB1002 is a pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qiu-Yang, Tao, Shu-Ya, Lu, Chang, Li, Jing-Jing, Li, Xiu-Miao, Yao, Jin, Jiang, Qin, Yan, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185286/ https://www.ncbi.nlm.nih.gov/pubmed/32323773 http://dx.doi.org/10.3892/mmr.2020.11056

Ejemplares similares

tRNA-derived fragment tRF-1001: A novel anti-angiogenic factor in pathological ocular angiogenesis
por: Jiang, Qin, et al.
Publicado: (2022)

Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms: A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
por: Nowak, Dawid G., et al.
Publicado: (2010)

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML
por: Ma, Shuang, et al.
Publicado: (2015)

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
por: Kimoto, Kenichi, et al.
Publicado: (2012)

FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis
por: Zhu, Xiaolong, et al.
Publicado: (2022)

P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION
por: Zhao, Ailin, et al.
Publicado: (2023)

Protein Kinase D1 Signaling in Angiogenic Gene Expression and VEGF-Mediated Angiogenesis
por: Ren, Bin
Publicado: (2016)

Complement Factor B Mediates Ocular Angiogenesis through Regulating the VEGF Signaling Pathway
por: Murray, Hannah, et al.
Publicado: (2021)

EDIL3 and VEGF Synergistically Affect Angiogenesis in Endothelial Cells
por: Niu, Xuping, et al.
Publicado: (2023)

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
por: Gerhardt, Holger, et al.
Publicado: (2003)

A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models
por: Zhang, Nannan, et al.
Publicado: (2017)

SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway
por: Peng, X, et al.
Publicado: (2014)

Metabolic Features of a Novel Trichoderma asperellum YNQJ1002 with Potent Antagonistic Activity against Fusarium graminearum
por: Ji, Huimin, et al.
Publicado: (2023)

Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications
por: Stahl, Andreas, et al.
Publicado: (2012)

Protective effects of SKLB023 on a mouse model of unilateral ureteral obstruction by the modulation of gut microbiota
por: Feng, Yanhuan, et al.
Publicado: (2018)

Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic Agent
por: Poupard, Nicolas, et al.
Publicado: (2017)

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer
por: Zhong, Lei, et al.
Publicado: (2017)

The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease
por: Holmes, David IR, et al.
Publicado: (2005)

Endothelial Semaphorin 3fb regulates Vegf pathway-mediated angiogenic sprouting
por: Watterston, Charlene, et al.
Publicado: (2021)

HDGF enhances VEGF-dependent angiogenesis and FGF-2 is a VEGF-independent angiogenic factor in non-small cell lung cancer
por: Eguchi, Ryoji, et al.
Publicado: (2020)

SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling
por: Barzegar, Mansoureh, et al.
Publicado: (2017)

SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway
por: Zhang, Jinhang, et al.
Publicado: (2018)

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
por: Banks, R. E., et al.
Publicado: (1998)

Impaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout mice
por: Zeng, Qiqun, et al.
Publicado: (2014)

VEGF165 induces differentiation of hair follicle stem cells into endothelial cells and plays a role in in vivo angiogenesis
por: Quan, Renfu, et al.
Publicado: (2017)

Endothelial Tip Cells in Ocular Angiogenesis: Potential Target for Anti-Angiogenesis Therapy
por: Siemerink, Martin J., et al.
Publicado: (2013)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Endothelial angiogenic activity and adipose angiogenesis is controlled by extracellular matrix protein TGFBI
por: Lee, Seul Gi, et al.
Publicado: (2021)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF(165)b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
por: Zhao, Min, et al.
Publicado: (2015)

Combined Transfer of Human VEGF165 and HGF Genes Renders Potent Angiogenic Effect in Ischemic Skeletal Muscle
por: Makarevich, Pavel, et al.
Publicado: (2012)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

CTLA-2 Alpha Is a Potent Inhibitor of Angiogenesis in Murine Ocular Tissue
por: Maruyama, Kazuichi, et al.
Publicado: (2021)

VEGF-independent angiogenic pathways induced by PDGF-C
por: Li, Xuri, et al.
Publicado: (2010)

SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling
por: Feng, Yanhuan, et al.
Publicado: (2018)

tmem33 is essential for VEGF-mediated endothelial calcium oscillations and angiogenesis
por: Savage, Aaron M., et al.
Publicado: (2019)

Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis
por: Li, Tao, et al.
Publicado: (2016)

Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis
por: Li, Yanping, et al.
Publicado: (2019)

WISP-1, a novel angiogenic regulator of the CCN family, promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression
por: Chuang, Jing-Yuan, et al.
Publicado: (2015)

The Effect and Mechanism of Vascular Endothelial Growth Factor (VEGF) on Tumor Angiogenesis in Gallbladder Carcinoma
por: XU, Dongqing, et al.
Publicado: (2019)

Draft Genome Sequence of Pectobacterium wasabiae Strain CFIA1002
por: Yuan, Kat (Xiaoli), et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ogkgmtu30hjon3dgerl9fqbc8t